Recent years have seen major advances in understanding the structure-function relationships of G protein-coupled receptors (GPCRs). This large superfamily of transmembrane receptors comprises over 800 ...
LOS ANGELES and SHANGHAI, Oct. 28. 2014 /PRNewswire/ -- The generation of high-resolution pictures of hundreds of medically important proteins known as G-protein coupled receptors (GPCRs) will be the ...
Since the beginning of the monoclonal antibody era led by the success of hybridoma technology in the middle of the 1970s, a variety of platform technologies, including antibody humanization, antibody ...
LOS ANGELES and SHANGHAI, Feb. 10, 2015 -- The GPCR Consortium, an international nonprofit collaboration that comprises leading academic research institutes in the United States and China and major ...
Scientists reveal how G protein-coupled receptors, major therapeutic drug targets, decode critical properties of their ligands. Through an international collaboration, scientists at St. Jude ...
New research illuminates a large and medically important family of proteins called G protein-coupled receptors (GPCRs). GPCRs sit in the cell membrane and sense various molecules outside the cell, ...
RuiYi and the iHuman Institute at ShanghaiTech University say they plan to apply RuiYi's iCAPS (Intermembranous Conformation Antigen Presenting System) technology to create novel monoclonal antibodies ...
Structure Therapeutics Inc. (NASDAQ:GPCR) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Structure Therapeutics Inc. (NASDAQ:GPCR) showcased preclinical findings for ACCG-2671 and ...
Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback